Skip to main content

Table 3 Themes, Categories and synthesised findings in relation to barriers to monitoring and management of cardiovascular and metabolic health of patients prescribed antipsychotic medicines

From: Barriers to monitoring and management of cardiovascular and metabolic health of patients prescribed antipsychotic drugs: a systematic review

Themes

Category

Synthesised findings

Social context and support [14,15,16, 27, 29]

 

Extrinsic factors

Lack of support from family/friends [12, 13, 21, 24]

Poor communication/ coordination between different health care providers /sectors [11, 12, 21, 22, 26, 28, 31]

Provider and healthcare system factors

Insufficient physician time [14, 20, 22, 23, 25, 26, 29]

Fragmentation of care [12, 20, 25, 27]

Patient- health-care professional relationship and communication [12, 21]

Issue of lack of clarity for responsibility for conducting physical health care [20, 21]

Lack of resources to manage healthy life style [11, 12, 17, 24, 27, 28]

Lack of resources

Lack of equipment or suitable space [26,27,28]

Staff turnover [26, 27]

Lack of qualified staff to manage physical health issues [25]

Primary care providers are not paid enough [25]

Lack of insurance [21]

Cost of running interventions or groups [26]

Lack of access to qualified psychiatric follow-up [16, 22, 25]

The Intervention site and the intervention characteristics

Intensity of the applied intervention [15, 19]

Leadership is not making managing physical health issues among patients with SMI a priority [21, 25, 26]

Difficulty traveling to specialised service [26]

Transportation problems [12]

Poor patient attendance [26]

Social context and support [14,15,16, 27, 29]

Family and community factor

Lack of support from family/friends [12, 13, 21, 24]

Mental health condition related disabilities [11, 13, 17, 19, 25, 29,30,31]

Mental health condition as a barrier

Intrinsic Factors

Severity of psychotic symptoms [17, 21, 22, 24, 25, 30, 31]

Consequences associated with the side effects of the antipsychotic medications [19, 21, 25, 29]

Stigma/Isolation/estrangement [12, 14, 20, 27, 28]

Motivation level among participants regarding general health issues [16,17,18, 21, 23,24,25,26,27]

Psychological factors

Participants views and behaviour toward specific intervention [15, 23, 26, 27, 29]

Participants’ views and behaviour regarding screening, monitoring of general health issues [11, 26, 31]

Stress [12, 18, 26]

Participants’ knowledge about healthy lifestyle [21, 22, 26, 30]

knowledge and skills

Participants’ knowledge about the medicines side effects [23, 27]

Lack of knowledge and training among health-care providers to manage physical health issues [14, 19, 20, 25, 26, 28]

Functional limitation [12, 24]

multiple-physical comorbidities

Negative effects of certain conditions e.g. pain [17]

Non-concordance with drug therapy [26]

Compliance issues

Social context and support [14,15,16, 27, 29]

Family and community factor

Lack of support from family/friends [12, 13, 21, 24]